Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for severe alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Topical treatment SM04554 safely promotes hair growth in male baldness.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Clascoterone is safe for the heart, even at high doses.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

RCS-01 cell therapy is safe and improves skin gene expression.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.